News
Akeso Inc. scored U.S. FDA approval of the PD-1 monoclonal antibody penpulimab in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or ...
A metabolic vulnerability of pancreatic ductal adenocarcinoma (PDAC) could be used to address this type of cancer that often resists treatments. Scientists at the University of Michigan have ...
BioHarvest Sciences Inc.’s BHST share price has dipped by 6.23%, which has investors questioning if this is right time to buy.
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of Dynamic Biopsy technology, today announced ...
The chemical industry is undergoing a pivotal transformation as it moves toward greener, more sustainable practices.
Cellulose, the most abundant biopolymer, is utilized to make a wide range of products like clothes and paper. Also, it helps ...
SAN DIEGO, CA - April 16, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is providing insight into the company’s enzymatic ...
Most energy generators currently employed within the electronics industry are based on inorganic piezoelectric materials that ...
ILLUSTRATION OF PGA IMMOBILIZATION BY Zr-MOFs VIA DYNAMIC EXCHANGE STRATEGY. GA, UNITED STATES, April 15, 2025 /EINPresswire / -- In a grou ...
A new study led by MDI Biological Laboratory identifies ML233 as a potent inhibitor of melanin production, offering promise for development of new treatments for pigment-related skin disorders and one ...
Key market drivers for malonic acid include its increasing demand in the production of bioplastics, pharmaceuticals, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results